Next Article in Journal
Serum Profiles of Cytokines in Behcet’s Disease
Previous Article in Journal
Predictors of Active Extravasation and Complications after Conventional Angiography for Acute Intraabdominal Bleeding
Previous Article in Special Issue
Emerging Metabolic Therapies in Pulmonary Arterial Hypertension
Article Menu
Issue 5 (May) cover image

Export Article

Open AccessReview
J. Clin. Med. 2017, 6(5), 48; doi:10.3390/jcm6050048

Nanoparticle-Mediated Drug Delivery System for Pulmonary Arterial Hypertension

1
Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan
2
Division of Cardiology, National Hospital Organization Okayama Medical Center, Okayama 701-1192, Japan
*
Author to whom correspondence should be addressed.
Academic Editor: Jane A. Leopold
Received: 24 January 2017 / Revised: 10 April 2017 / Accepted: 22 April 2017 / Published: 29 April 2017
(This article belongs to the Special Issue Novel Therapeutic Approaches for Pulmonary Arterial Hypertension)
View Full-Text   |   Download PDF [345 KB, uploaded 2 May 2017]   |  

Abstract

Nanoparticles have been used as a novel drug delivery system. Drug-incorporated nanoparticles for local delivery might optimize the efficacy and minimize the side effects of drugs. The efficacy and safety of intratracheal administration of prostacyclin analog (beraprost) -incorporated nanoparticles and imatinib (a PDGF-receptor tyrosine kinase inhibitor) -incorporated nanoparticles in Sugen-hypoxia-normoxia or monocrotaline rat models of pulmonary arterial hypertension (PAH) and in human PAH-pulmonary arterial smooth muscle cells have been reported. The use of inhaled drug-incorporated nanoparticles might be a novel approach for the treatment of PAH. View Full-Text
Keywords: pulmonary arterial hypertension; prostacyclin; nanoparticle; drug delivery system pulmonary arterial hypertension; prostacyclin; nanoparticle; drug delivery system
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Nakamura, K.; Matsubara, H.; Akagi, S.; Sarashina, T.; Ejiri, K.; Kawakita, N.; Yoshida, M.; Miyoshi, T.; Watanabe, A.; Nishii, N.; Ito, H. Nanoparticle-Mediated Drug Delivery System for Pulmonary Arterial Hypertension. J. Clin. Med. 2017, 6, 48.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
J. Clin. Med. EISSN 2077-0383 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top